3/4/2025The United Labs' UBT251 Injection Receives FDA Approval for Phase II C...

3/4/2025BeiGene's TEVIMBRA Approved in U.S. for First-line Treatment of Advanc...

3/4/2025HighTide Thera Publishes Positive Phase 2 Data on HTD1801 for Type 2 D...

3/3/2025Innovent's IBI363 Enters Pivotal Trial, Challenging Keytruda in Melano...

2/28/2025Henlius Initiates Phase 1b/2 Trial for PD-L1 ADC HLX43 in Solid Tumors

2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...

2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA

2/27/2025Akeso Initiates First-in-Human Phase 1 Trial for HER3-Targeting ADC AK...

2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...

2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars

2/27/2025IVIEW Thera Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic...

2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...

2/26/2025YolTech Therapeutics Announces Positive Clinical Data for In Vivo Gene...

2/26/2025In Vivo Gene Editing Product ART002 Achieves Saturation of Pharmacolog...

2/25/2025BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial

2/25/2025Ardelyx/Fosun'sTenapanor Approved for Hyperphosphatemia in CKD Dialysi...

2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...

2/21/2025Hengrui Medicine Advances Dual GLP-1/GIP Agonist HRS9531 with First Ph...

2/21/2025MediLink's YL217 Received FDA Clearance of IND Application

2/20/2025Ascletis Reports Positive Interim Results from U.S. Phase Ib Study of ...

2/18/2025NovoCodex's ARX788 Demonstrates Efficacy in HER2-Positive Advanced Bre...

2/18/2025BioKin Initiates Phase III Trial in China for BL-B01D1 in NSCLC

2/18/2025Huadong Medicine Announces Positive Results from HDM1005 Clinical Tria...

2/17/2025Betta Pharma's Xcovery Initiates EMA Approval Process for Ensartinib i...

2/17/2025BioNTech Initiates Phase 1/2 Trial for BNT327 and BNT323 Combination i...

2/17/2025CSPC's SYS6005 ADC Enters Phase I Clinical Trials in China

2/14/2025China Approves Novo Nordisk's Semaglutide Injection for New Indication

2/14/2025NMPA Approves Sinocelltech's Finotonlimab for R/M HNSCC

2/14/2025Trinomab's TNM002: A New Passive Immunization Agent for Emergency Teta...

2/14/2025NMPA Approves SciClone's Vibativ for Drug-Resistant Gram-Positive Infe...

Page:11/18 Total number of articles:511: [First][<<] [9] [10] [11] [12] [13] [>>] [End]